Memorial Sloan Kettering Cancer Center-led researchers have identified a small molecule called gliocidin that kills ...

Compounds that act on mechanisms associated with resistance of glioblastoma stem cells show efficacy in mouse models. Failure to cure cancer has been attributed to the fact that typical cytotoxic ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

研究者Kim博士说道，如今免疫疗法已经给诸如 黑色素 ...

Trials with mice in whom the researchers implanted human glioblastoma cells have already shown that the treatment is very ...

In 2016, cancer biologist Johanna Joyce of the Memorial Sloan Kettering Cancer Center published a study in Science that ...

BPGbio, Inc., a leading biology-first, AI-powered clinical-stage biopharma company focused on mitochondrial biology and ...

A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma, one of the most aggressive forms of brain cancer, becomes resistant to treatment, and ...

CAR T-cell therapy shows promise for solid tumors like glioblastoma. New engineering strategies and clinical trial results ...